BioRestorative Therapies, Inc.(BRTX)— Stock Profile, AI Score & Financials
Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
BioRestorative Therapies, Inc. (BRTX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores BRTX at 29.9/100 on a 32-signal composite quality model, placing it at rank #2,508 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q1 2026), BioRestorative Therapies, Inc. reports quarterly revenue of $23.2K, net income of $-2.2M. Top institutional holders of BRTX by reported 13-F value include JANE STREET GROUP, HRT FINANCIAL, XTX Topco Ltd, based on the most recent SEC filings. BRTX trades on the Nasdaq exchange and files with the SEC under CIK 1505497. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BRTX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for BioRestorative Therapies, Inc. directly from SEC EDGAR.
AI Quality Score
29.9/100
AI Rank
#2,508
Revenue
$23.2K
Net Income
$-2.2M
BRTX key financials by period
BioRestorative Therapies, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2025
10-K
$359.7K
$-14.2M
—
FY 2024
10-K
$401.0K
$-9.0M
—
FY 2023
10-K/A
$145.8K
$-10.4M
—
FY 2022
10-K/A
$119.8K
$-13.2M
—
FY 2021
10-K/A
$46.0K
$-44.3M
—
FY 2020
10-K
$77.0K
$-11.3M
—
Institutions holding BRTX
Institutional investors reporting a position in BioRestorative Therapies, Inc. on SEC Form 13F.
